Search

everythinglearnresearchcommunity

for

Search:↓

PRP-based treatments can increase hair density, but results vary among individuals.

TNF-alpha inhibitors can cause various immune-related skin issues.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Dupilumab can cause rare side effects like a rash on the face and neck.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Ustekinumab helped three kids with alopecia areata regrow hair.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Dupilumab helps children with alopecia areata regrow hair safely.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Dupilumab may help regrow hair in people with severe alopecia.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.